Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...